MOG and myeloid sarcoma: Finally, the majority of patients in the study had bilateral ON, a relatively rare finding in MS patients; unfortunately, testing of myelin oligodendrocyte glycoprotein antibodies could not be performed as this facility has only been implemented at SQUH within the last 3 years.